Form 4: UnitedHealth Group CFO John F. Rex Reports Changes in Beneficial Ownership

John F. Rex, President & CFO of UnitedHealth Group, reports acquisition and disposal of common stock and dividend equivalents related to restricted stock units.

Summary

• John F. Rex, the President & CFO of UnitedHealth Group, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On June 25, 2024, Rex acquired 76.356 shares of common stock through dividend equivalents paid on outstanding restricted stock units.
• On the same day, Rex disposed of 6,791 shares of common stock held indirectly through a trust.
• Following these transactions, Rex directly owns 166,357.719 shares of UnitedHealth Group common stock.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't convey any positive or negative sentiment about the company's performance or prospects.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies like UnitedHealth Group. It provides transparency to investors regarding the financial interests of key executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for executives at publicly traded companies, including competitors of UnitedHealth Group such as CVS Health, Anthem (Elevance Health), and Cigna.
• The reported transactions are typical for executives receiving stock-based compensation and managing their personal investment portfolios.
• The level of detail provided in the Form 4 is consistent with SEC regulations and industry norms.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the stock ownership of a key executive.
• The transactions themselves are unlikely to have a significant impact on the company's operations or financial performance.

Key Dates